Are you Dr. Schachner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 84 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
690 N 14th St
3rd Floor
Beaumont, TX 77702Phone+1 409-899-7180Fax+1 409-899-7186
Summary
- Dr. Jay Schachner, MD is an oncologist in Beaumont, Texas. He is currently licensed to practice medicine in Texas and Maryland. He is affiliated with CHRISTUS Southeast Texas Hospital - St. Elizabeth, Baptist Hospitals of Southeast Texas, and CHRISTUS Southeast Texas Jasper Memorial.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1984 - 1986
- University of MarylandResidency, Internal Medicine, 1982 - 1984
- Johns Hopkins University/Bayview Medical CenterInternship, Internal Medicine, 1981 - 1982
- Rutgers New Jersey Medical SchoolClass of 1981
Certifications & Licensure
- TX State Medical License 1986 - 2026
- MD State Medical License 1983 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 207 citationsFludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Michael J. Keating, Hagop M. Kantarjian, Susan O'Brien, Charles Koller, Moshe Talpaz
Journal of Clinical Oncology. 1991-01-01 - 17 citationsCytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia.Jay Schachner, Hagop M. Kantarjian, Willard T. Dalton, Kenneth B. McCredie, M. Keating
Leukemia. 1988-10-01 - 36 citationsPhiladelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.Mordechai Shtalrid, Moshe Talpaz, Mark Blick, Paolo Romero, Hagop M. Kantarjian
Journal of Clinical Oncology. 1988-10-01